The offerings will also support the ongoing design and planning of a cultural development project integrating: LONDON, March 3, 2026 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) ("MDJM" or the "Company") announced that it has completed two offerings totaling an aggregate of approximately USD 8.5 million in February and March 2026 to advance its global animation production and cultural infrastructure initiatives. On February 11, 2026, the Company closed an upsized public offering, raising gross proceeds of approx ...

"We're in an asset bubble, and TQI can help you navigate it profitably"I am Ahan Vashi, a seasoned investor with professional background in equity research, private equity, and software engineering. I currently serve as the Chief Financial Engineer at The Quantamental Investor, a community pursuing financial freedom through bold, active investing with proactive risk management.TQI was established in July 2022 with a singular mission to make investing simple, fun, and profitable for all investors. In alignme ...

So far in 2026, the market has been quite volatile. This is mostly from fear of AI disruption, but also because of rising geopolitical tensions.Formerly known as "The Dividend Collectuh." Top 1% of financial experts on TipRanks. Contributing analyst to the iREIT+Hoya Capital investment group. Dividend Collection Agency is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to ...

Forward-Looking Statements RESTON, Va., March 03, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) is scheduled to issue its fourth quarter fiscal year 2026 results before market open on Monday, March 16, 2026. SAIC executive management will discuss operational and financial results in a conference call beginning at 10:00 a.m. EDT, following the issuance of the company's earnings press release. The conference call will be webcast simultaneously to the public through a link on ...

Just because a business is popular among consumers, it doesn't always mean that the stock is a winner. That's certainly been the case with Walt Disney (NYSE: DIS). The media and entertainment giant's shares have tanked 44% in the past five years (as of Feb. 27). Should you buy the dip? Here are three things Disney investors need to know so that they can be better informed. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensabl ...

KUALA LUMPUR, Malaysia, March 03, 2026 (GLOBE NEWSWIRE) -- Founder Group Limited (NASDAQ: FGL) (“FGL” or the “Company”) today announced that on February 25, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550(a)(2) (the “Listing Rule”). Nasdaq determined that the closing bid price of the Company’s Class A ordinary shares has been ...

Core Insights - Tempus AI, Inc. and Merck have announced an expanded multi-year collaboration to enhance the discovery and development of precision medicine biomarkers, particularly in oncology [1][2] - The partnership aims to leverage Tempus' de-identified multimodal datasets and advanced AI capabilities to improve patient outcomes and accelerate the development of candidate therapies [2][3] Company Overview - Tempus is a technology company focused on advancing precision medicine through AI applications in healthcare, boasting one of the largest libraries of multimodal data [4] - The company provides AI-enabled solutions to physicians, aiming to personalize patient care and facilitate the discovery and development of optimal therapeutics [4] Collaboration Details - Under the agreement, Merck will utilize Tempus' Lens Platform and Workspaces environment, which is powered by a significant GPU infrastructure, to conduct complex analyses on multimodal datasets [2] - The collaboration is expected to enhance Merck's precision oncology strategy by applying AI/ML capabilities to discover novel biomarkers and inform drug combinations in their early pipeline [3]

JACKSON, WYOMING / ACCESS Newswire / March 3, 2026 / Kultura Brands, Inc. (OTCID:LTNC) ("Kultura" or the "Company"), formerly known as Labor Smart, Inc., today announced that it has established a dedicated brokerage account with E*Trade from Morgan Stanley, to facilitate board-approved investment activities, including the potential purchase of its common stock in the open market, subject to applicable securities laws and regulations, including SEC and FINRA requirements, as well as the Company's internal co ...

To learn more about DataXchange and AmendX, visit here and here. S&P Global remains focused on delivering comprehensive solutions for investors navigating private markets, through trusted private markets data, analytics and insights. To learn more, visit here. New platforms address operational bottlenecks and streamline amendment workflows for rapidly growing private credit and syndicated loan markets NEW YORK, March 3, 2026 /PRNewswire/ -- S&P Global (NYSE: SPGI) today announced the launch of DataXchange a ...

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 38th Annual Roth Conference taking place on March 22-24, 2026.CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the duration of the event. 38th Annual Roth Conference for ...